Cancer risk seen with J&J foot gel: FDA
WASHINGTON (Reuters) - A Johnson & Johnson foot gel used by diabetics may increase the risk of cancer and death, U.S. health officials said on Thursday in announcing an investigation into the issue.
<p><img src="http://feeds.reuters.com/~a/reuters/healthNews?i=g37wEm" border="0"></img> (http://feeds.reuters.com/~a/reuters/healthNews?a=g37wEm)</p><div class="feedflare">
<img src="http://feeds.reuters.com/~f/reuters/healthNews?i=dEds2hF" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=dEds2hF) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=GhDDjBf" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=GhDDjBf) <img src="http://feeds.reuters.com/~f/reuters/healthNews?i=Yh0Bnnf" border="0"></img> (http://feeds.reuters.com/~f/reuters/healthNews?a=Yh0Bnnf)
</div><img src="http://feeds.reuters.com/~r/reuters/healthNews/~4/259225696" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/healthNews/~3/259225696/idUSN2737486320080327